Efficacy and tolerability of long-term, open-label, mixed amphetamine salts extended release in adolescents with ADHD

CNS Spectrums

Volumn 10, Issue 10 SUPPL. 15, 2005, Pages 14-21

  Spencer, Thomas J ^a   Biederman, Joseph ^b   Wilens, Timothy E ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; MIXED AMPHETAMINE SALT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADHD RATING SCALE IV; ADOLESCENT; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL GLOBAL IMPRESSIONS IMPROVEMENT RATING SCALE; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EXTENDED RELEASE FORMULATION; FEMALE; FLU LIKE SYNDROME; GENERAL CONDITION IMPROVEMENT; HEADACHE; HOSTILITY; HUMAN; HYPERACTIVITY; HYPERTENSION; IMPULSIVENESS; INFECTION; INJURY; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; OPEN STUDY; OUTCOMES RESEARCH; PHARYNGITIS; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SYMPTOM; TACHYCARDIA; THOUGHT DISORDER; WEIGHT REDUCTION;

EID: 27244446196     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900014103     Document Type: Article

References (25)

1. Academy of Pediatrics, Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000;105:1158-1170.
2. Barkley RA, Fischer M, Edelbrook C, et al. The adolescent outcome of hyperactive children diagnosed by research criteria, 1: an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990;29:546-557.
3. Biederman J, Faraone S, MilbergerS, et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1996;35:343-351.
4. Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr Drugs. 2003;5:787-794.
5. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry. 2004;45:195-211.
6. Zito JM, Safer DJ, DosReis S, et al. Psychotropic practice patterns for youth. A 10-year perspective. Arch Pediatr Adolesc Med. 2003;157:17-25.
7. American Academy of Pediatrics. Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder. Clinical practice guideline: treatment of the school-age child with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108:1033-1044.
8. American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41:26S-49S.
9. Findling RL, Dogin JW. Psychopharmacology of ADHD: children and adolescents. J Clin Psychiatry. 1998;59:42-49.
10. Connors CK. Forty years of methylphenidate treatment in attention-deficit/hyperactivity disorder. J Atten Disord. 2002;6(suppl 1):S17-S30.
11. MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics. 2004;113:754-761.
12. Ahmann PA, Theye FW, Berg R, Linquist AJ, Van Erem AJ, Campbell LR. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics. 2001;107:e10.
13. Stein MA, Sarampote CS, Waldman ID, et al. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2003;112:e404.
14. Greenhill LL, Findling RL, Swanson JM, for the ADHD Study Group. A doubleblind, placebo-controlled study of modified release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002;109:e39.
15. Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD. Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1990;29:702-709.
16. Wilens T, McBurnett K, Bukstein O, et al. A multisite, controlled trial of OROS methylphenidate in the treatment of adolescents with ADHD. Arch Pediatr Adolesc Med. 2005. In press.
17. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Efficacy and safety of Adderall XR in the management of attention-deficit/ hyperactivity disorder in adolescent patients: a randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2005. In press.
18. Diagnostic and Statistical Manual of Mental Disorders. 4th ed text rev. Washington, DC: American Psychiatric Association; 2000.
19. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-aged Children-Present and Lifetime version (K-SADS-PL). J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
20. DuPaul GJ, Power T, Anastopoulos A, Reed R. The ADHD Rating Scale-IV: Checklist, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
21. SAS Institute. SAS/STAT Software: Changes and Enhancements Through Release 6.12, 1997. Cary, NC: SAS Institute.
22. Wilens TE, Spencer TJ, Biederman J. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in adolescents with ADHD. CNS Spectr. 2005;10(10 suppl 15):22-30.
23. McGough JJ, Biederman J, Wigal SB, et al. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005;44(6):530-538.
24. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001;58:115-182.
25. Abikoff H, Hechtman L, Klein RG, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.; Am Acad Child Adolesc Psychiatry. 2004;43:802-811.